Ledger.Open graph →
SEC Form D · filed May 18, 2017

Vivace Therapeutics, Inc

Offering
$25.0M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Mateo, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Jun Wu · San Mateo, CADirectorShuang Qiao · San Mateo, CAExec · DirectorLeonard Post · San Mateo, CAExec · DirectorEdward Hu · San Mateo, CADirectorTim Shannon · San Mateo, CADirectorVladan Milosevic · VICTORIA, British Columbia, CanadaExec · DirectorDragoljub Jujic · VICTORIA, British Columbia, CanadaDirectorAlexander M. Abell · Chicago, ILDirectorTim Daniels · VICTORIA, British Columbia, CanadaExec · DirectorBlake Fallis · VICTORIA, British Columbia, CanadaDirectorBruce Karsh · Los Angeles, CAExec · DirectorRichard T. Miller · Boston, MADirectorSaverio M. Flemma · Boston, MADirectorAndrew C. Tarica · Boston, MADirectorEduardo M. Inclan · San Juan, Puerto RicoExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗